Alnylam Pharmace. buy Joe130978
Start price
04.08.22
/
50%
€210.00
Target price
04.08.23
-
Performance (%)
-17.71%
End price
04.08.23
€172.80
Summary
This prediction ended on 04.08.23 with a price of €172.80. The price of Alnylam Pharmace. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.71%. Joe130978 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -5.845% | -5.845% | 7.020% | 34.102% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by Joe130978 for this prediction
In the thread Alnylam Pharmace. diskutieren
Joe130978 hat das Wertpapier Alnylam Pharmace. in seinem Wikifolio Die ganze Welt der Biotechs gekauft.
In the thread Trading Alnylam Pharmace.
Die von Joe130978 gewählte maximale Laufzeit wurde überschritten